GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

71

Mediterranean Diet in IBD: IJG March 2026

Introduction Diet plays an important role in the pathogenesis and management of inflammatory bowel disease (IBD). Among various dietary patterns, the Mediterranean diet (MD)—rich in fruits, vegetables, whole...

72

Microbiome Signature at IBD Onset: Gastroenterology | March 2026

Introduction Most microbiome studies in inflammatory bowel disease (IBD) are confounded by prior treatment, long disease duration, and inconsistent sequencing/bioinformatic methods—making “core” signatures hard to trust. This systematic...

73

Faecal S100A9- A new IBD Biomarker: Gastroenterology | March 2026

Why Look Beyond Fecal Calprotectin? Fecal calprotectin (FC) is one of the most widely used noninvasive biomarkers in inflammatory bowel disease (IBD). It reflects intestinal inflammation through the...

74

A Normal UCEIS Is Zero, not Three: Gastroenterology | March 26

Introduction The Ulcerative Colitis Endoscopic Index of Severity (UCEIS) was developed to standardise the endoscopic assessment of ulcerative colitis activity. It evaluates vascular pattern, bleeding, and erosions/ulcers, generating...

75

VECTORS Trial - BMJ Open Gastro Feb. 26

The VECTORS trial, a landmark phase 4 randomized controlled trial (RCT), was recently published in BMJ Open Gastroenterology on February 26. This trial represents a significant step forward...

76

Caffeine and IBD - JGH Feb 26

This is the first comprehensive meta-analysis examining the relationship between caffeine intake and inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), synthesising data from...

77

Subcutaneous Guselkumab for Crohn’s: Interpreting GRAVITI Carefully- Gastroenterology Feb.26

Introduction Fully subcutaneous biologic regimens are attractive in Crohn’s disease because they can reduce infusion burden and improve convenience. The GRAVITI trial evaluated a fully subcutaneous induction and...

78

Inpatient IBD Care: Practical Guidance From the AGA- Gastroenterology Feb.26

Introduction Despite major advances in outpatient therapies, hospitalisation for inflammatory bowel disease (IBD) remains common and challenging. Outcomes vary widely, with persistent problems such as: hospital-acquired complications, delays...

79

From Treatment to Prevention in IBD - Gastroenterology Feb.26

Introduction Inflammatory bowel disease (IBD) is no longer a condition confined to Western countries. With globalisation, urbanisation, and changing environmental exposures, IBD incidence is rising worldwide, while prevalence...

80

Nutrition management puzzle in IBD- Front. Med. 2026

Nutritional Management in IBD: Current Insights Importance of Nutrition in IBD: Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is influenced by genetic,...

Previous
178913
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer